An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function-Reference-Cited by-同舟云学术

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function

Published:2011-08 Issue:3 Volume:80 Page:282-287
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Holtkamp Frank A.,de Zeeuw Dick,Thomas Merlin C.,Cooper Mark E.,de Graeff Pieter A.,Hillege Hans J.L.,Parving Hans-Henrik,Brenner Barry M.,Shahinfar Shahnaz,Lambers Heerspink Hiddo J.

Publisher

Elsevier BV

Subject

Nephrology

Reference22 articles.

1. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;N Engl J Med,2001

2. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes;Lewis;N Engl J Med,2001

3. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes;Parving;N Engl J Med,2001

4. Preventing microalbuminuria in type 2 diabetes;Ruggenenti;N Engl J Med,2004

5. Renal protective effect of enalapril in diabetic nephropathy;Bjorck;BMJ,1992

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Krüppel-like factor 2 is an endoprotective transcription factor in diabetic kidney disease;American Journal of Physiology-Cell Physiology;2024-08-01

2. Kidney and cardiovascular-protective benefits of combination drug therapies in chronic kidney disease associated with type 2 diabetes;BMC Nephrology;2024-08-01

3. Chronische Niereninsuffizienz bei Typ-2-Diabetes – die stille Bedrohung einer Multisystemerkrankung;Aktuelle Kardiologie;2024-07-31

4. Chronic kidney disease in type 2 diabetes: The size of the problem, addressing residual renal risk and what we have learned from the CREDENCE trial;Diabetes, Obesity and Metabolism;2024-07-23

5. State-of-the-Art-Review: Mechanisms of Action of SGLT2 Inhibitors and Clinical Implications;American Journal of Hypertension;2024-07-17